Manufacturers/Novartis Pharmaceuticals Corporation

Novartis Pharmaceuticals Corporation

92 drugs in NADAC|0 Generic,92 Brand

View Recalls (6)

Novartis Pharmaceuticals Corporation lists 92 NDCs in the CMS NADAC file (0 generic, 92 brand), at an average NADAC of $762.12 per unit, with a week-over-week move of -0.0% across products that moved. The firm's full portfolio, pricing trend, and FDA recalls are listed below.

Total Drugs

92

0G / 92B

Avg Price / Unit

$762.1164

$0.44 – $24391.66

Avg 7d Change

-0.01%

Across 34 drugs with changes

7d Activity

181658 flat

of 92 total drugs

Portfolio Price Trend

Monthly average NADAC price across all drugs

Frequently Asked Questions

How many drugs does Novartis Pharmaceuticals Corporation make?

Novartis Pharmaceuticals Corporation lists 92 NDCs in the CMS NADAC file — 0 generic and 92 brand products.

What is the average price of Novartis Pharmaceuticals Corporation drugs?

The average NADAC across Novartis Pharmaceuticals Corporation's portfolio is $762.1164 per unit, ranging from $0.4361 to $24391.6620.

What types of drugs does Novartis Pharmaceuticals Corporation make?

Novartis Pharmaceuticals Corporation makes drugs across 24 FDA pharmacologic classes. The most common by NDC count are Angiotensin 2 Receptor Blocker (25), Central Nervous System Stimulant (17), Calcium Channel Blocker (13), Dihydropyridine Calcium Channel Blocker (13), Kinase Inhibitor (10).

Has Novartis Pharmaceuticals Corporation had any drug recalls?

6 FDA recalls are matched to Novartis Pharmaceuticals Corporation in the openFDA feed, most recently on Nov 22, 2023.

How has Novartis Pharmaceuticals Corporation's pricing changed recently?

Over the past 7 days, 18 Novartis Pharmaceuticals Corporation products rose and 16 fell, with a portfolio-wide average change of -0.0%.

Drug Portfolio

92 drugs total, 92 shown

Drug Price 7d Change
KESIMPTA 20 MG/0.4 ML PEN
ofatumumab
$24391.6620
per ML
-0.20%
COSENTYX 150 MG/ML SYRINGE
secukinumab
$7923.3134
per ML
COSENTYX SENSOREADY 150 MG/ML PEN
secukinumab
$7869.8320
per ML
SANDOSTATIN LAR DEPOT 30 MG KT
octreotide acetate
$6680.8500
per EA
SANDOSTATIN LAR DEPOT 20 MG KT
octreotide acetate
$4412.0643
per EA
COSENTYX UNOREADY 300 MG/2 ML PEN (1 PEN)
secukinumab
$4085.7198
per ML
-0.11%
COSENTYX (150 MG/ML) 300 MG DOSE-2 SYRINGES
secukinumab
$3965.6440
per ML
COSENTYX SENSOREADY 300 MG DOSE/2 PENS (150 MG/PEN)
secukinumab
$3961.2495
per ML
-0.39%
SANDOSTATIN LAR DEPOT 10 MG KT
octreotide acetate
$3387.5280
per EA
AFINITOR 10 MG TABLET
everolimus
$462.0394
per EA
GILENYA 0.5 MG CAPSULE
Fingolimod hcl
$414.7110
per EA
KISQALI 400 MG DAILY DOSE
ribociclib
$346.9469
per EA
GLEEVEC 400 MG TABLET
imatinib mesylate
$328.0342
per EA
GLEEVEC 400 MG TABLET
imatinib mesylate
$328.0342
per EA
KISQALI 600 MG DAILY DOSE
ribociclib
$289.7167
per EA
TASIGNA 200 MG CAPSULE
nilotinib
$94.1452
per EA
TASIGNA 200 MG CAPSULE
nilotinib
$94.1452
per EA
GLEEVEC 100 MG TABLET
imatinib mesylate
$90.8197
per EA
TOBRADEX EYE OINTMENT
tobramycin and dexamethasone
$89.7774
per GM
-0.01%
TOBREX 0.3% EYE OINTMENT
tobramycin
$84.5555
per GM
-0.17%
BETOPTIC S 0.25% EYE DROP
betaxolol hydrochloride
$42.8790
per ML
BETOPTIC S 0.25% EYE DROP
betaxolol hydrochloride
$42.6242
per ML
AZOPT 1% EYE DROPS
brinzolamide
$35.1697
per ML
FEMARA 2.5 MG TABLET
letrozole
$27.1160
per EA
ZORTRESS 0.75 MG TABLET
everolimus
$27.0419
per EA
EXELON 4.6 MG/24HR PATCH
rivastigmine
$22.0229
per EA
EXELON 13.3 MG/24HR PATCH
rivastigmine
$22.0078
per EA
EXELON 9.5 MG/24HR PATCH
rivastigmine
$21.8225
per EA
+1.42%
TRILEPTAL 600 MG TABLET
oxcarbazepine
$19.2741
per EA
-0.10%
ZORTRESS 0.5 MG TABLET
everolimus
$17.8041
per EA
DIOVAN HCT 320-25 MG TABLET
valsartan and hydrochlorothiazide
$16.4965
per EA
LOTREL 10-40 MG CAPSULE
amlodipine besylate and benazepril hydrochloride
$15.6209
per EA
EXFORGE HCT 10-320-25 MG TAB
amlodipine valsartan and hydrochlorothiazide
$15.4477
per EA
EXFORGE 10-320 MG TABLET
amlodipine besylate and valsartan
$15.3942
per EA
SANDIMMUNE 100 MG CAPSULE
cyclosporine
$15.3370
per EA
MYFORTIC 360 MG TABLET
mycophenolic acid
$14.6414
per EA
DIOVAN HCT 160-25 MG TABLET
valsartan and hydrochlorothiazide
$13.0470
per EA
RITALIN LA 40 MG CAPSULE
methylphenidate hydrochloride
$12.7255
per EA
DIOVAN 320 MG TABLET
valsartan
$12.6830
per EA
+0.09%
RITALIN LA 30 MG CAPSULE
methylphenidate hydrochloride
$12.3878
per EA
LOTREL 5-20 MG CAPSULE
amlodipine besylate and benazepril hydrochloride
$12.2080
per EA
EXFORGE 10-160 MG TABLET
amlodipine besylate and valsartan
$12.1271
per EA
RITALIN LA 20 MG CAPSULE
methylphenidate hydrochloride
$12.1023
per EA
RITALIN LA 10 MG CAPSULE
methylphenidate hydrochloride
$12.0700
per EA
XIIDRA 5% EYE DROPS
Lifitegrast
$11.8317
per EA
+0.01%
DIOVAN HCT 320-12.5 MG TAB
valsartan and hydrochlorothiazide
$11.7935
per EA
ENTRESTO SPRINKLE 15-16 MG PLT
Sacubitril and Valsartan
$11.6416
per EA
-0.06%
ENTRESTO 97 MG-103 MG TABLET
Sacubitril and Valsartan
$11.5954
per EA
+0.07%
ENTRESTO 97 MG-103 MG TABLET
Sacubitril and Valsartan
$11.5954
per EA
+0.07%
ENTRESTO 24 MG-26 MG TABLET
Sacubitril and Valsartan
$11.5908
per EA
-0.01%
ENTRESTO 24 MG-26 MG TABLET
Sacubitril and Valsartan
$11.5908
per EA
-0.01%
LOTREL 5-10 MG CAPSULE
amlodipine besylate and benazepril hydrochloride
$11.5553
per EA
ENTRESTO 49 MG-51 MG TABLET
Sacubitril and Valsartan
$11.5543
per EA
+0.08%
ENTRESTO 49 MG-51 MG TABLET
Sacubitril and Valsartan
$11.5543
per EA
+0.08%
NEORAL 100 MG GELATIN CAPSULE
cyclosporine
$11.5421
per EA
DIOVAN HCT 160-12.5 MG TAB
valsartan and hydrochlorothiazide
$11.4803
per EA
-0.48%
LOTREL 10-20 MG CAPSULE
amlodipine besylate and benazepril hydrochloride
$11.2952
per EA
EXFORGE 5-320 MG TABLET
amlodipine besylate and valsartan
$10.9314
per EA
EXFORGE 5-160 MG TABLET
amlodipine besylate and valsartan
$10.6508
per EA
DIOVAN HCT 80-12.5 MG TABLET
valsartan and hydrochlorothiazide
$10.5648
per EA
TRILEPTAL 300 MG TABLET
oxcarbazepine
$10.4514
per EA
DIOVAN 160 MG TABLET
valsartan
$10.0374
per EA
+0.32%
EXFORGE HCT 10-160-25 MG TAB
amlodipine valsartan and hydrochlorothiazide
$9.7743
per EA
DIOVAN 80 MG TABLET
valsartan
$9.3214
per EA
-0.17%
EXFORGE HCT 5-160-12.5 MG TAB
amlodipine valsartan and hydrochlorothiazide
$8.5559
per EA
EXFORGE HCT 10-160-12.5 MG TAB
amlodipine valsartan and hydrochlorothiazide
$8.4532
per EA
EXFORGE HCT 5-160-25 MG TAB
amlodipine valsartan and hydrochlorothiazide
$8.4511
per EA
DIOVAN 40 MG TABLET
valsartan
$7.8269
per EA
MYFORTIC 180 MG TABLET
mycophenolic acid
$7.2874
per EA
TEGRETOL XR 400 MG TABLET
carbamazepine
$6.4954
per EA
-0.30%
TRILEPTAL 150 MG TABLET
oxcarbazepine
$5.7216
per EA
FOCALIN XR 35 MG CAPSULE
dexmethylphenidate hydrochloride
$5.4251
per EA
FOCALIN XR 40 MG CAPSULE
dexmethylphenidate hydrochloride
$5.4141
per EA
COARTEM TABLETS
artemether and lumefantrine
$5.3628
per EA
FOCALIN XR 25 MG CAPSULE
dexmethylphenidate hydrochloride
$5.1391
per EA
FOCALIN XR 15 MG CAPSULE
dexmethylphenidate hydrochloride
$4.9167
per EA
+0.03%
FOCALIN XR 20 MG CAPSULE
dexmethylphenidate hydrochloride
$4.9049
per EA
+0.03%
FOCALIN XR 10 MG CAPSULE
dexmethylphenidate hydrochloride
$4.7606
per EA
+0.03%
FOCALIN XR 30 MG CAPSULE
dexmethylphenidate hydrochloride
$4.7573
per EA
-0.23%
FOCALIN XR 5 MG CAPSULE
dexmethylphenidate hydrochloride
$4.6981
per EA
+0.02%
SANDIMMUNE 25 MG CAPSULE
cyclosporine
$4.3773
per EA
TEGRETOL XR 200 MG TABLET
carbamazepine
$3.2414
per EA
+0.08%
TEGRETOL 200 MG TABLET
carbamazepine
$3.0395
per EA
+0.02%
NEORAL 25 MG GELATIN CAPSULE
cyclosporine
$2.8879
per EA
TRILEPTAL 300 MG/5 ML SUSP
oxcarbazepine
$1.9293
per ML
+0.05%
RITALIN 20 MG TABLET
methylphenidate hydrochloride
$1.6315
per EA
-0.01%
TEGRETOL XR 100 MG TABLET
carbamazepine
$1.6239
per EA
+0.01%
FOCALIN 10 MG TABLET
dexmethylphenidate hydrochloride
$1.3297
per EA
RITALIN 10 MG TABLET
methylphenidate hydrochloride
$1.1328
per EA
+0.01%
FOCALIN 5 MG TABLET
dexmethylphenidate hydrochloride
$0.9206
per EA
-0.27%
RITALIN 5 MG TABLET
methylphenidate hydrochloride
$0.7974
per EA
-0.29%
TEGRETOL 100 MG/5 ML SUSP
carbamazepine
$0.4361
per ML
+0.06%

FDA Recalls (6)

Recalls matched by company name. Verify current status with FDA.

D-0144-2024
Ongoing
Class I

SANDIMMUNE Oral Solution (cyclosporine oral solution, USP) 100 mg/mL, 50 mL bottle, Rx Only, Manufactured by: DELPHARM Huningue S.A.S., Huningue, France, Distributed by: Novartis Pharmaceuticals Corporation, East Hanover, New Jersey 07936. NDC 0078-0110-22

Crystallization: bottles of Sandimmune Oral Solution were determined to contain crystals

Initiated: 11/22/2023
D-1543-2022
Terminated
Class II

Neoral soft gelatin capsules (cyclosporine capsules, USP) Modified, 25 mg, Rx Only, 30 Soft Gelatin Capsules per carton, Mfg by: Novartis Pharmaceuticals Corporation, East Hanover, NJ 07936, NDC # 0078-0246-15.

CGMP deviations: Out of specification results obtained during routine stability testing for ethanol content.

Initiated: 9/16/2022
D-0985-2022
Terminated
Class III

Xiidra (lifitegrast ophthalmic solution) 5% PROFESSIONAL SAMPLE, packaged in a) 5 single-use containers (0.2 mL each vial) (NDC 54092-606-07) and b) 4 pouches x 5 single-use containers (NDC 54092-606-04), Rx Only, Manufactured for: Shire US Inc., 300 Shire Way, Lexington, MA 02421.

Failed Impurities/Degradation Specifications.

Initiated: 5/10/2022
D-0984-2022
Terminated
Class III

Xiidra (lifitegrast ophthalmic solution) 5% PROFESSIONAL SAMPLE, packaged in a) 5 single-use containers (0.2 mL each vial) (NDC 0078-0911-95) and b) 4 pouches x 5 single-use containers (NDC 0078-0911-94), Rx Only, Manufactured by: The Ritedose Corporation Columbia, SC 29203; Distributed by: Novartis Pharmaceuticals Corporation East Hanover, NJ 07936.

Failed Impurities/Degradation Specifications.

Initiated: 5/10/2022
D-0983-2022
Terminated
Class III

Xiidra (lifitegrast ophthalmic solution) 5%, packaged in a) 60 Single-Use Containers: 12 pouches x 5 single-use containers (0.2 mL each vial) (NDC 54092-606-01) and b) 5-Single-Use Containers (NDC 54092-606-06), Rx Only, Manufactured for: Shire US Inc., 300 Shire Way, Lexington, MA 02421.

Failed Impurities/Degradation Specifications.

Initiated: 5/10/2022
D-0982-2022
Terminated
Class III

Xiidra (lifitegrast ophthalmic solution), packaged in a) 60 Single-Use Containers: 12 pouches x 5 single-use containers (0.2 mL each vial) (NDC 0078-0911-12) and b) 5- Single-Use Containers (NDC 0078-0911-05) Rx Only, Manufactured by: The Ritedose Corporation, Columbia, SC 29203, Distributed by: Novartis Pharmaceuticals Corporation, East Hanover, NJ 07936.

Failed Impurities/Degradation Specifications.

Initiated: 5/10/2022